The Oura IPO is drawing roughly four times the orders on offer as the smart-ring maker markets up to $2.2 billion in a U.S. listing, people familiar with the deal told reporters on September 26. Pricing is targeted for September 29, with shares expected to begin trading on the Nasdaq under the ticker OURA.
Oura and selling stockholders are offering 50 million shares at a marketed range of $40 to $44, according to company filings and Reuters. At the top of that range, the sale implies about a $14.1 billion market capitalization on outstanding shares—or roughly $15–15.6 billion on a fully diluted basis.
How the Oura IPO is structured
Of the 50 million shares, Oura plans to sell 13.5 million while existing holders—including names such as Forerunner Ventures and Lifeline Ventures in coverage of the book—offer 36.5 million. Selling stockholders also intend to grant underwriters a 30-day option for up to 7.5 million more shares. Oura will not receive proceeds from shares sold by those stockholders.
Goldman Sachs, Morgan Stanley, and J.P. Morgan are lead underwriters, with Allen & Co. and Jefferies also listed among bookrunners in deal coverage. Banks expected to stop taking orders Monday afternoon, according to a September 26 Briefs report citing people familiar with the offering.
Demand, Lilly interest, and growth metrics
Reuters reported that Eli Lilly indicated interest in buying up to $100 million of shares, while Dragoneer signaled interest in up to $300 million. Orders totaling about four times the stock on offer put Oura among the strongest consumer-tech debuts in a fall window that has otherwise seen volatility and postponed listings.
An updated S-1 narrative says Oura now expects to end fiscal 2026 with about 5.7 million paid members—roughly 96 percent year-over-year growth—driven largely by Oura Ring 5 sales. The Finnish-founded company pitches the ring as a health-intelligence platform tracking sleep, heart metrics, and activity for consumers, teams, and research partners.
Why markets are watching wearable IPOs
Wearable and digital-health listings have been scarce at billion-dollar scale this year. Coverage noted Oura could be among the earliest 2026 deals above $1 billion to clear after other large IPOs slipped. A successful Nasdaq debut would also test how public investors value recurring membership revenue versus one-time hardware sales.
Competitors in rings, watches, and continuous monitoring will watch whether the Oura IPO prices at the top of the range and how shares trade after the open. Privacy and clinical-grade claims remain long-term diligence items for institutions that buy health-data platforms.
What happens the week of September 29
Retail investors will not get the same allocations as the institutions filling a four-times-covered book, but the marketing roadshow still spills into social feeds where Ring 5 owners compare waitlists and subscription tiers. That consumer buzz matters: wearable IPOs live or die on whether hardware cycles keep refreshing the paid-member funnel after the listing pop fades.
Regulatory risk is quieter but real. Any public wearable firm faces questions about health claims, data sharing with research partners, and how membership churn behaves if a rival watch or ring undercuts price. Oura’s S-1 growth story leans on Ring 5 momentum; sustaining 96 percent member growth into a public-market spotlight is a different test.
If the book holds, pricing on September 29 would set the stage for OURA’s first session on the Nasdaq Global Select Market. Terms can still change while discussions continue; spokespeople for Oura and Goldman Sachs declined comment in the Briefs report.
For consumers who already wear the ring to track recovery and sleep, the Oura IPO is less about ticker drama than whether a public company keeps shipping quieter hardware and stronger health insights. For Wall Street, it is a referendum on whether smart rings can carry a double-digit-billion valuation into 2027.
Related coverage: Brightline Bankruptcy Filing Aims to Cut Heavy Debt and Stock Market News: Nasdaq Tumbles as Big Tech Earnings Shake Investor Confidence.